Doctors Issue First Guide to Treat Cancer During Pregnancy

Pregnant women diagnosed with cancer no longer have to choose between their health and their baby's wellbeing, thanks to new medical guidelines that show many treatments are safe during pregnancy.

The Society for Maternal-Fetal Medicine just published the first comprehensive, evidence-based guide for diagnosing and treating cancer during pregnancy. With about 1 in 1,000 pregnancies now affected by cancer, doctors finally have clear direction on how to help these patients.

"As cancer rates continue to rise, clinicians are seeing more patients with cancer during pregnancy, but guidance has been limited until now," said Dr. Moti Gulersen, a maternal-fetal medicine specialist who helped develop the guidelines. The guidance covers nine cancer types and outlines safe treatment options at every stage of pregnancy.

The news comes as cancer diagnoses during pregnancy have been rising across the United States. Breast cancer affects up to 1 in 3,000 pregnancies, and 10 percent of thyroid cancers are now diagnosed during pregnancy or within a year after birth.

For years, doctors avoided treating cancer during pregnancy because of unknowns about fetal safety. Many women faced impossible decisions or delayed critical care. Recent research now shows reassuring health outcomes after treatment for many pregnancy-related cancers.

The new guidelines emphasize that cancer treatment should never be withheld just because someone is pregnant. Surgery can be performed safely at any stage of pregnancy. Chemotherapy is recommended after 12 weeks, and doctors can use ultrasounds and MRIs to monitor both mother and baby throughout treatment.

The Ripple Effect

This guidance changes everything for families facing cancer during pregnancy. Doctors can now create personalized treatment plans that consider cancer type, pregnancy stage, and patient preferences, all backed by solid evidence.

The guidelines also ensure pregnant cancer patients have access to full reproductive options and multidisciplinary care teams. Regular fetal monitoring every 3 to 4 weeks helps doctors track baby's growth regardless of treatment type.

These advances in oncology mean expecting mothers can receive effective cancer therapy while prioritizing their baby's wellbeing. Both lives can be protected, and neither has to be sacrificed for the other.

Thousands of families each year will now face cancer during pregnancy with expert guidance, hope, and proven treatment paths forward.